The pressure to deliver new medicines to the patient continues to grow along with increases in compound failure rate, thus putting the current R&D model at risk. Analysis has shown that increasing the three-dimensionality of potential drug candidates decreases the risk of failure and improves binding selectivity and frequency. For this reason many workers have taken a new look at the power of photochemistry
随着失败率的增加,向患者提供新药的压力也在不断增加,从而使当前的R&D模式面临风险。分析表明,增加潜在候选药物的三维性可降低失败的风险,并提高结合选择性和频率。由于这个原因,许多工作者对光
化学的力量有了新的认识,将光
化学作为产生新颖的富含sp 3的支架用于药物发现计划的手段。在这里,我们报告了一系列具有固有3D特性(PMI和PBF得分)的2,4-甲基脯
氨酸的设计,合成和计算结构分析,其明显高于更广泛的AbbVie Rule 3(Ro3)系列。